TTop stories Read More FDA approves Vera Therapeutics kidney disease treatmentJuly 7, 2026 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
TTop stories Read More Anthropic, AI powerhouse, announces it will begin developing drugs of its ownJuly 1, 2026 Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…
TTop stories Read More Anthropic releases Claude Science, sees Claude Code level impactJune 30, 2026 Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…
TTop stories Read More Medicare obesity drug GLP-1 coverage starting July 1June 30, 2026 Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage…
TTop stories Read More FDA pilot program aims to speed up early-stage clinical trialsJune 22, 2026 Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
TTop stories Read More Lilly shares safety, tolerability data on its next-gen obesity drugJune 7, 2026 Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
TTop stories Read More Revolution Medicines’ pancreatic cancer drug proving hard to getJune 5, 2026 Amy Johnston is distraught and readily admits that she is “grasping at straws.” Diagnosed last year with pancreatic…
TTop stories Read More RevMed’s pancreatic cancer, Akeso, Eli Lilly: Readout NewsletterJune 2, 2026 Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
TTop stories Read More New hormone protocol cut relapse risk in prostate cancer trialMay 31, 2026 Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of…
TTop stories Read More CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill FoundayoMay 28, 2026 An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…
TTop stories Read More Eli Lilly: Single-shot gene therapy lowered cholesterol in early studyMay 25, 2026 Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in…
TTop stories Read More White House adds generic drugs to direct-to-consumer TrumpRx siteMay 20, 2026 President Donald Trump speaks to introduce the TrumpRx website in the South Court Auditorium of the White House…